Skip to main content

Advertisement

SpringerLink
Log in

Peripheral tumor necrosis factor-a-induced protein 8-like 2 mRNA level for predicting 3-month mortality of patients with acute ischemic stroke

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Tumor necrosis factor-a-induced protein 8-like 2 (TIPE2) is a novel negative regulator for maintaining immune homeostasis. This study aimed to investigate TIPE2 mRNA in peripheral blood mononuclear cells for predicting 3-month functional outcomes and mortality of patients with acute ischemic stroke. A total of 182 consecutive patients were prospective collected, and there were 55 (30.2%) patients with unfavorable outcome and 33 (18.1%) patients died at the end of 3 months. The area under the operating characteristic curve (AUC) for TIPE2 mRNA was 0.810 (95% CI 0.733–0.886) for mortality and 0.740 (95% CI 0.662–0.818) for unfavorable outcome. The model incorporating National Institutes of Health Stroke Scale (NIHSS) plus TIPE2 showed significantly (P = 0.04) increased discrimination power (AUC = 0.925, 95% CI 0.874–0.976) for mortality than NIHSS (AUC = 0.882, 95% CI 0.833–0.932). Furthermore, NIHSS plus TIPE2 showed a significant improvement of both integrated discrimination index (IDI) and net reclassification index (NRI) as compared with NIHSS (IDI = 0.224, 95% CI 0.150–0.299, P < 0.001; NRI = 1.119, 95% CI 0.810–1.429, P < 0.001). The pruned time-dependent tree analysis showed that patients with NIHSS ≥ 5.5 and TIPE2 mRNA < 5.2 had rather high 3-month mortality. In conclusion, TIPE2 mRNA improved the diagnostic value of NIHSS score, and patients with NIHSS ≥ 5.5 and TIPE2 mRNA < 5.2 had high 3-month mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Tu WJ, Zeng XW, Deng A, Zhao SJ, Luo DZ, Ma GZ, Wang H, Liu Q (2017) Circulating FABP4 (fatty acid—binding protein 4) is a novel prognostic biomarker in patients with acute ischemic stroke. Stroke 48(6):1531–1538. https://doi.org/10.1161/STROKEAHA.117.017128

    Article  CAS  PubMed  Google Scholar 

  2. Sisirak V, Sally B, D’Agati V, Martinez-Ortiz W, Ozcakar ZB, David J, Rashidfarrokhi A, Yeste A, Panea C, Chida AS, Bogunovic M, Ivanov II, Quintana FJ, Sanz I, Elkon KB, Tekin M, Yalcinkaya F, Cardozo TJ, Clancy RM, Buyon JP, Reizis B (2016) Digestion of chromatin in apoptotic cell microparticles prevents autoimmunity. Cell 166(1):88–101. https://doi.org/10.1016/j.cell.2016.05.034

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Esenwa CC, Elkind MS (2016) Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke. Nat Rev Neurol 12(10):594–604. https://doi.org/10.1038/nrneurol.2016.125

    Article  CAS  PubMed  Google Scholar 

  4. Sun H, Gong S, Carmody RJ, Hilliard A, Li L, Sun J, Kong L, Xu L, Hilliard B, Hu S, Shen H, Yang X, Chen YH (2008) TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. Cell 133(3):415–426. https://doi.org/10.1016/j.cell.2008.03.026

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Zhang Y, Wei X, Liu L, Liu S, Wang Z, Zhang B, Fan B, Yang F, Huang S, Jiang F, Chen YH, Yi F (2012) TIPE2, a novel regulator of immunity, protects against experimental stroke. J Biol Chem 287(39):32546–32555. https://doi.org/10.1074/jbc.M112.348755

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Li D, Song L, Fan Y, Li X, Li Y, Chen J, Zhu F, Guo C, Shi Y, Zhang L (2009) Down-regulation of TIPE2 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clin Immunol 133(3):422–427. https://doi.org/10.1016/j.clim.2009.08.014

    Article  CAS  PubMed  Google Scholar 

  7. Xi W, Hu Y, Liu Y, Zhang J, Wang L, Lou Y, Qu Z, Cui J, Zhang G, Liang X, Ma C, Gao C, Chen Y, Liu S (2011) Roles of TIPE2 in hepatitis B virus-induced hepatic inflammation in humans and mice. Mol Immunol 48(9–10):1203–1208. https://doi.org/10.1016/j.molimm.2011.03.002

    Article  CAS  PubMed  Google Scholar 

  8. Kong L, Liu K, Zhang YZ, Jin M, Wu BR, Wang WZ, Li W, Nan YM, Chen YH (2013) Downregulation of TIPE2 mRNA expression in peripheral blood mononuclear cells from patients with chronic hepatitis C. Hepatol Int 7(3):844–849. https://doi.org/10.1007/s12072-013-9435-2

    Article  PubMed  Google Scholar 

  9. Wang LY, Fan YC, Zhao J, Gao S, Sun FK, Han J, Yang Y, Wang K (2014) Elevated expression of tumour necrosis factor-alpha-induced protein 8 (TNFAIP8)-like 2 mRNA in peripheral blood mononuclear cells is associated with disease progression of acute-on-chronic hepatitis B liver failure. J Viral Hepat 21(1):64–73. https://doi.org/10.1111/jvh.12116

    Article  CAS  PubMed  Google Scholar 

  10. Zhao Q, Zhao M, Dong T, Zhou C, Peng Y, Zhou X, Fan B, Ma W, Han M, Liu S (2015) Tumor necrosis factor-alpha-induced protein-8 like-2 (TIPE2) upregulates p27 to decrease gastic cancer cell proliferation. J Cell Biochem 116(6):1121–1129. https://doi.org/10.1002/jcb.25068

    Article  CAS  PubMed  Google Scholar 

  11. Li Y, Li X, Liu G, Sun R, Wang L, Wang J, Wang H (2015) Downregulated TIPE2 is associated with poor prognosis and promotes cell proliferation in non-small cell lung cancer. Biochem Biophys Res Commun 457(1):43–49. https://doi.org/10.1016/j.bbrc.2014.12.080

    Article  CAS  PubMed  Google Scholar 

  12. Liu QQ, Zhang FF, Wang F, Qiu JH, Luo CH, Zhu GY, Liu YF (2015) TIPE2 inhibits lung cancer growth attributing to promotion of apoptosis by regulating some apoptotic molecules expression. PLoS One 10(5):e0126176. https://doi.org/10.1371/journal.pone.0126176

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Cao X, Zhang L, Shi Y, Sun Y, Dai S, Guo C, Zhu F, Wang Q, Wang J, Wang X, Chen YH, Zhang L (2013) Human tumor necrosis factor (TNF)-alpha-induced protein 8-like 2 suppresses hepatocellular carcinoma metastasis through inhibiting Rac1. Mol Cancer 12(1):149. https://doi.org/10.1186/1476-4598-12-149

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Zhang Z, Qi H, Hou S, Jin X (2013) TIPE2 mRNA overexpression correlates with TNM staging in renal cell carcinoma tissues. Oncol Lett 6(2):571–575. https://doi.org/10.3892/ol.2013.1388

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Li XM, Su JR, Yan SP, Cheng ZL, Yang TT, Zhu Q (2014) A novel inflammatory regulator TIPE2 inhibits TLR4-mediated development of colon cancer via caspase-8. Cancer Biomark 14(4):233–240. https://doi.org/10.3233/CBM-140402

    Article  CAS  PubMed  Google Scholar 

  16. Zhang S, Zhang Y, Wei X, Zhen J, Wang Z, Li M, Miao W, Ding H, Du P, Zhang W, He M, Yi F (2010) Expression and regulation of a novel identified TNFAIP8 family is associated with diabetic nephropathy. Biochim Biophys Acta 1802(11):1078–1086. https://doi.org/10.1016/j.bbadis.2010.08.003

    Article  CAS  PubMed  Google Scholar 

  17. Ma Y, Liu X, Wei Z, Wang X, Wang Z, Zhong W, Li Y, Zhu F, Guo C, Zhang L, Wang X (2013) The expression and significance of TIPE2 in peripheral blood mononuclear cells from asthmatic children. Scand J Immunol 78(6):523–528. https://doi.org/10.1111/sji.12110

    Article  CAS  PubMed  Google Scholar 

  18. Fan YC, Wang N, Sun YY, Xiao XY, Wang K (2015) TIPE2 mRNA level in PBMCs serves as a novel biomarker for predicting short-term mortality of acute-on-chronic hepatitis B liver failure: a prospective single-center study. Medicine (Baltimore) 94(39):e1638. https://doi.org/10.1097/MD.0000000000001638

    Article  CAS  Google Scholar 

  19. Jia L, Gui B, Tian P, Yao G, Fu R, Wang L, Ge H, Ou Y (2013) TIPE2, a novel biomarker for clinical chronic kidney allograft rejection. Artif Organs 37(2):221–225. https://doi.org/10.1111/j.1525-1594.2012.01527.x

    Article  CAS  PubMed  Google Scholar 

  20. Boehme AK, Esenwa C, Elkind MS (2017) Stroke risk factors, genetics, and prevention. Circ Res 120(3):472–495. https://doi.org/10.1161/CIRCRESAHA.116.308398

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Tsivgoulis G, Patousi A, Pikilidou M, Birbilis T, Katsanos AH, Mantatzis M, Asimis A, Papanas N, Skendros P, Terzoudi A, Karamanli A, Kouroumichakis I, Zebekakis P, Maltezos E, Piperidou C, Vadikolias K, Heliopoulos I (2018) Stroke incidence and outcomes in Northeastern Greece: the Evros Stroke Registry. Stroke 49(2):288–295. https://doi.org/10.1161/STROKEAHA.117.019524

    Article  PubMed  Google Scholar 

  22. Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V et al (1989) Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20(7):864–870

    Article  CAS  PubMed  Google Scholar 

  23. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24(1):35–41

    Article  PubMed  Google Scholar 

  24. Ilzecka J, Stelmasiak Z (2000) Practical significance of ischemic stroke OCSP (Oxfordshire Community Stroke Project) classification. Neurol Neurochir Pol 34(1):11–22

    CAS  PubMed  Google Scholar 

  25. Sims JR, Gharai LR, Schaefer PW, Vangel M, Rosenthal ES, Lev MH, Schwamm LH (2009) ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes. Neurology 72(24):2104–2110. https://doi.org/10.1212/WNL.0b013e3181aa5329

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Bonita R, Beaglehole R (1988) Recovery of motor function after stroke. Stroke 19(12):1497–1500

    Article  CAS  PubMed  Google Scholar 

  27. Katan M, Fluri F, Morgenthaler NG, Schuetz P, Zweifel C, Bingisser R, Muller K, Meckel S, Gass A, Kappos L, Steck AJ, Engelter ST, Muller B, Christ-Crain M (2009) Copeptin: a novel, independent prognostic marker in patients with ischemic stroke. Ann Neurol 66(6):799–808. https://doi.org/10.1002/ana.21783

    Article  CAS  PubMed  Google Scholar 

  28. Palm F, Pussinen PJ, Safer A, Tervahartiala T, Sorsa T, Urbanek C, Becher H, Grau AJ (2018) Serum matrix metalloproteinase-8, tissue inhibitor of metalloproteinase and myeloperoxidase in ischemic stroke. Atherosclerosis 271:9–14. https://doi.org/10.1016/j.atherosclerosis.2018.02.012

    Article  CAS  PubMed  Google Scholar 

  29. Wu H, Guo P, Jin Z, Li X, Yang X, Tang C, Wang Y, Ke J (2018) Serum levels of irisin predict short-term outcomes in ischemic stroke. Cytokine. https://doi.org/10.1016/j.cyto.2018.02.017

    Article  PubMed  PubMed Central  Google Scholar 

  30. Amantea D, Nappi G, Bernardi G, Bagetta G, Corasaniti MT (2009) Post-ischemic brain damage: pathophysiology and role of inflammatory mediators. FEBS J 276(1):13–26. https://doi.org/10.1111/j.1742-4658.2008.06766.x

    Article  CAS  PubMed  Google Scholar 

  31. Xia W, Han J, Huang G, Ying W (2010) Inflammation in ischaemic brain injury: current advances and future perspectives. Clin Exp Pharmacol Physiol 37(2):253–258. https://doi.org/10.1111/j.1440-1681.2009.05279.x

    Article  CAS  PubMed  Google Scholar 

  32. Suzuki S, Tanaka K, Suzuki N (2009) Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects. J Cereb Blood Flow Metab 29(3):464–479. https://doi.org/10.1038/jcbfm.2008.141

    Article  CAS  PubMed  Google Scholar 

  33. Chun HJ, Zheng L, Ahmad M, Wang J, Speirs CK, Siegel RM, Dale JK, Puck J, Davis J, Hall CG, Skoda-Smith S, Atkinson TP, Straus SE, Lenardo MJ (2002) Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 419(6905):395–399. https://doi.org/10.1038/nature01063

    Article  CAS  PubMed  Google Scholar 

  34. Salmena L, Hakem R (2005) Caspase-8 deficiency in T cells leads to a lethal lymphoinfiltrative immune disorder. J Exp Med 202(6):727–732. https://doi.org/10.1084/jem.20050683

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Freundt EC, Bidere N, Lenardo MJ (2008) A different TIPE of immune homeostasis. Cell 133(3):401–402. https://doi.org/10.1016/j.cell.2008.04.017

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Muruet W, Rudd A, Wolfe CDA, Douiri A (2018) Long-term survival after intravenous thrombolysis for ischemic stroke: a propensity score-matched cohort with up to 10-year follow-up. Stroke 49(3):607–613. https://doi.org/10.1161/STROKEAHA.117.019889

    Article  PubMed  PubMed Central  Google Scholar 

  37. Smith EE, Kent DM, Bulsara KR, Leung LY, Lichtman JH, Reeves MJ, Towfighi A, Whiteley WN, Zahuranec DB, American Heart Association Stroke C (2018) Effect of dysphagia screening strategies on clinical outcomes after stroke: a systematic review for the 2018 guidelines for the early management of patients with acute ischemic stroke. Stroke 49(3):e123–e128. https://doi.org/10.1161/STR.0000000000000159

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We greatly appreciated the technical assistance with statistical analysis during the revision provided by Prof. Tao Zhang (Department of Biostatistics, School of Public Health, Shandong University), and Dr. Xinglin Chen (EmpowerStat software, developed by the statistician Prof. Chang-Zhong Chen, Harvard University).

Funding

This work was supported by the Grant from the National Natural Science Foundation of China (81373635) and the Key Research and Development Plan of Shandong Province (2016GSF121044).

Author information

Authors and Affiliations

  1. Department of Neurology, Jinan Central Hospital affiliated to Shandong University, Jiefang Road 105#, Jinan, 250013, China

    Yuan-Yuan Zhang, Na-Na Huang, Yan-Shuang Li, Jing Zhao, Dong Wang, Feng Zhang & Xiao-Hong Li

  2. Department of Hepatology, Qilu Hospital of Shandong University, Jinan, 250012, China

    Yu-Chen Fan

Authors
  1. Yuan-Yuan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Na-Na Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yu-Chen Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yan-Shuang Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jing Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Dong Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Feng Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Xiao-Hong Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xiao-Hong Li.

Ethics declarations

Conflicts of interest

The authors declare that they have no competing interests.

Ethical statement

The study was approved by the local ethics committee of the Jinan Central Hospital affiliated to Shandong University.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 17 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, YY., Huang, NN., Fan, YC. et al. Peripheral tumor necrosis factor-a-induced protein 8-like 2 mRNA level for predicting 3-month mortality of patients with acute ischemic stroke. J Neurol 265, 2573–2586 (2018). https://doi.org/10.1007/s00415-018-9036-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-018-9036-z

Keywords

Search

Navigation